314 related articles for article (PubMed ID: 25225963)
41. Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.
Pasternak AO; Jurriaans S; Bakker M; Prins JM; Berkhout B; Lukashov VV
PLoS One; 2009 Dec; 4(12):e8490. PubMed ID: 20046870
[TBL] [Abstract][Full Text] [Related]
42. New Potential MicroRNA Biomarkers in Human Immunodeficiency Virus Elite Controllers, Human Immunodeficiency Virus Infections, and Coinfections with Hepatitis B Virus or Hepatitis C Virus.
Mahmud Hussen B; Noori M; Sayad B; Ebadi Fard Azar M; Sadri Nahand J; Bayat M; Babaei F; Karampour R; Bokharaei-Salim F; Mirzaei H; Moghoofei M; Bannazadeh Baghi H
Intervirology; 2023; 66(1):122-135. PubMed ID: 37699384
[TBL] [Abstract][Full Text] [Related]
43. Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1.
Lee SY; Park YK; Yoon CH; Kim K; Kim KC
BMC Med Genomics; 2019 Jan; 12(1):3. PubMed ID: 30626383
[TBL] [Abstract][Full Text] [Related]
44. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
45. The interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls.
Sachdeva R; Shilpi RY; Simm M
Innate Immun; 2014 Feb; 20(2):173-83. PubMed ID: 23751822
[TBL] [Abstract][Full Text] [Related]
46. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
[TBL] [Abstract][Full Text] [Related]
47. Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy.
Consuegra I; Gasco S; Serramía MJ; Jiménez JL; Mellado MJ; Muñoz-Fernández MÁ
Sci Rep; 2021 Dec; 11(1):23477. PubMed ID: 34873266
[TBL] [Abstract][Full Text] [Related]
48. HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.
Côrtes FH; Passaes CP; Bello G; Teixeira SL; Vorsatz C; Babic D; Sharkey M; Grinsztejn B; Veloso V; Stevenson M; Morgado MG
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):377-385. PubMed ID: 25564106
[TBL] [Abstract][Full Text] [Related]
49. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
[TBL] [Abstract][Full Text] [Related]
50. Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy.
Zhang W; Morshed MM; Noyan K; Russom A; Sönnerborg A; Neogi U
Sci Rep; 2017 Apr; 7(1):666. PubMed ID: 28386076
[TBL] [Abstract][Full Text] [Related]
51. Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors.
Van Hecke C; Trypsteen W; Malatinkova E; De Spiegelaere W; Vervisch K; Rutsaert S; Kinloch-de Loes S; Sips M; Vandekerckhove L
EBioMedicine; 2019 Mar; 41():443-454. PubMed ID: 30770230
[TBL] [Abstract][Full Text] [Related]
52. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
Hatano H; Delwart EL; Norris PJ; Lee TH; Dunn-Williams J; Hunt PW; Hoh R; Stramer SL; Linnen JM; McCune JM; Martin JN; Busch MP; Deeks SG
J Virol; 2009 Jan; 83(1):329-35. PubMed ID: 18945778
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil E; Ikediobi U; Sutton RE
Yale J Biol Med; 2017 Jun; 90(2):245-259. PubMed ID: 28656011
[TBL] [Abstract][Full Text] [Related]
54. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
55. Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors.
Díez-Fuertes F; De La Torre-Tarazona HE; Calonge E; Pernas M; Alonso-Socas MDM; Capa L; García-Pérez J; Sakuntabhai A; Alcamí J
Sci Rep; 2019 Oct; 9(1):14265. PubMed ID: 31582776
[TBL] [Abstract][Full Text] [Related]
56. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.
Gupta P; Liu B; Wu JQ; Soriano V; Vispo E; Carroll AP; Goldie BJ; Cairns MJ; Saksena NK
Virology; 2014 Feb; 450-451():336-49. PubMed ID: 24503097
[TBL] [Abstract][Full Text] [Related]
57. Elite controllers long-term non progressors present improved survival and slower disease progression.
Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
[TBL] [Abstract][Full Text] [Related]
59. Rapid development of HIV elite control in a patient with acute infection.
Morley D; Lambert JS; Hogan LE; De Gascun C; Redmond N; Rutishauser RL; Thanh C; Gibson EA; Hobbs K; Bakkour S; Busch MP; Farrell J; McGetrick P; Henrich TJ
BMC Infect Dis; 2019 Sep; 19(1):815. PubMed ID: 31533639
[TBL] [Abstract][Full Text] [Related]
60. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
